By Product, By Method, By Application, By End User, and By Region – Market Forecast, 2025–2034
The global forensic genomics market size was valued at USD 470.27 million in 2024, growing at a CAGR of 14.6% from 2025–2034. Rising global crime rates and terrorism threats are driving demand for advanced forensic genomics solutions, while government initiatives to build national DNA databases are further driving adoption.
Forensic genomics applies advanced DNA sequencing and analysis technologies to strengthen criminal investigations and identity verification. It also supports applications such as paternity testing and disaster victim identification. The industry is driven by technologies such as next-generation sequencing platforms, polymerase chain reaction systems, DNA extraction kits and bioinformatics software. These solutions provide accurate DNA profiling and enable the detection of genetic variations to help law enforcement agencies, forensic laboratories and research institutions address complex cases. Their adoption in criminal justice, civil law and security improves the accuracy of evidence processing and strengthens the reliability of forensic outcomes.
In forensic practice, NGS and PCR-based systems generate detailed genetic profiles from minimal or degraded DNA samples, while bioinformatics tools support data interpretation and comparison against reference databases. Cloud-based platforms and digital solutions enable secure data storage and real-time collaboration between forensic laboratories and investigative agencies, reducing case backlogs and improving efficiency. For example, in January 2023, QIAGEN completed the USD 150 million acquisition of Verogen to expand its leadership in next-generation sequencing for human identification and forensics. The deal adds Verogen’s MiSeq FGx platform and GEDmatch databases, with projected 2023 sales of about USD 20 million. The advancement is expected to streamline laboratory operations and strengthen the use of genomics in forensic science.
The forensic genomics market is expanding as demand grows for advanced DNA profiling in criminal investigations, cross-border security and human identification. Also, the growing technological progress in sequencing accuracy, automation and cost efficiency is further propelling market growth. Moreover, the government funding for forensic science programs and the establishment of national DNA databases in countries such as the U.S. and UK are driving wider adoption. In addition, rapidly increasing focus on rapid and portable DNA analysis, combined with improvements in data analytics and sample preparation methods is expected to drive long-term industry growth.
Rising Global Crime Rates and Terrorism Threats: The rising incidence of violent crimes, organized criminal activities and terrorism-related threats is creating strong demand for advanced forensic genomics solutions. The Global Organized Crime Index 2023 shows that organized crime continues to grow worldwide, with 83% of the global population living under high levels of criminality. Also, according to the Global Terrorism Index (GTI) 2024, terrorism-related deaths rose by 22 percent in 2023, reaching 8,352, the highest level recorded since 2017. Law enforcement agencies are under pressure to improve investigation accuracy and speed in cases involving cross-border crime and terrorism. Forensic genomics enables rapid and precise DNA profiling, even from degraded samples, which strengthens evidence reliability in complex cases. The ability to link suspects, victims and crime scenes with higher accuracy is driving adoption across forensic laboratories worldwide. This factor is positioning forensic genomics as an essential tool for modern criminal investigation systems.
Government Initiatives to Establish National DNA Databases: Increasing government programs to build and expand national DNA databases are accelerating the adoption of forensic genomics technologies. Developed countries prioritized the creation of large-scale databases to improve criminal identification and enhance public safety. These initiatives are strengthening law enforcement to support civil applications such as missing persons identification and disaster victim recovery. The integration of advanced sequencing systems and bioinformatics platforms into national infrastructure ensures more efficient storage, retrieval and comparison of genetic profiles. As more governments adopt such measures, the demand for forensic genomics solutions continues to grow in the coming years.
Product Analysis
Based on product, the segmentation includes instruments, consumables, and software and services. The instruments segment dominated the market in 2024, driven by widespread adoption of sequencing systems, PCR platforms and capillary electrophoresis tools in forensic laboratories. These instruments are essential for generating reliable DNA profiles that meet judicial standards. Moreover, its ability to analyze degraded and complex samples makes them indispensable in criminal investigations. In addition, rising technological upgrades in instrument sensitivity and throughput are driving its dominant position in the forensic genomics market.
The software and services segment is projected to grow at the fastest CAGR during the forecast period, due to rising demand for advanced bioinformatics and secure data management solutions. Increasing case complexity requires software tools that rapidly compare DNA profiles against large-scale databases. Also, the growing adoption of cloud-based forensic platforms supports real-time collaboration between agencies. In addition, service providers are expanding offerings such as data interpretation and validation, fueling rapid growth.
Method Analysis
Based on method, the segmentation includes next-generation sequencing (NGS), capillary electrophoresis (CE), polymerase chain reaction (PCR), microarray, and others. The next-generation sequencing (NGS) segment dominated the market in 2024, driven by its ability to deliver high-resolution genetic profiling from even degraded DNA samples. NGS provides detailed insights that strengthen the accuracy of criminal investigations and human identification. Moreover, growing integration with bioinformatics tools supports advanced data interpretation. In addition, forensic laboratories prefer NGS platforms for large-scale database comparisons that propels the segment’s dominance.
The polymerase chain reaction (PCR) segment is projected to grow at the fastest CAGR during the forecast period, due to its rapid amplification of small DNA samples. PCR is rapidly adopted for cases involving limited or compromised biological evidence. Also, lower operational cost compared to sequencing systems makes it accessible for smaller laboratories. In addition, advancements in portable PCR systems are expanding field-based forensic applications fueling its growth.
Application Analysis
Based on application, the segmentation includes criminal investigation, human identification, paternity and kinship testing, missing person identification, disaster victim identification, and other application. The criminal investigation segment dominated the market in 2024, driven by rising crime rates and the need for accurate evidence analysis. Forensic genomics enhances case resolution by linking suspects, victims and crime scenes with higher precision. Moreover, national law enforcement agencies are increasingly adopting advanced DNA profiling tools to strengthen judicial outcomes. In addition, integration of genomic data into criminal databases further supports the dominance of this application segment.
The human identification segment is projected to grow at the fastest CAGR during the forecast period, due to rising use of genomic tools in missing person cases and disaster victim recovery. This method provides accurate identity verification where traditional approaches fall short. Also, government-backed initiatives to establish large DNA databases support broader adoption. In addition, portable sequencing solutions are enabling quicker results in field applications, fueling strong market growth.
End User Analysis
Based on end user, the segmentation includes forensic laboratories, law enforcement agencies, research and academic institutes, government agencies, and contract research organizations (CROs). The forensic laboratories segment dominated the market in 2024, driven by their central role in processing DNA samples for criminal investigations and civil cases. These laboratories house advanced sequencing systems and bioinformatics tools that deliver reliable evidence admissible in court. Moreover, rising investments to modernize forensic infrastructure are strengthening their capacity. For instance, in March 2025, the Government of India approved USD 11.48 million for establishing an 8th Central Forensic Science Laboratory (CFSL) in Jammu and allocated USD 98.82 million under the National Forensic Infrastructure Enhancement Scheme to set up seven additional CFSLs across the country. In addition, growing collaborations with government agencies are expanding laboratory resources that fuels its leading position in the market.
The ambulatory surgery centers segment is projected to grow at the fastest CAGR during the forecast period, due to increasing preference for outpatient methods and minimally invasive surgeries. These centers provide cost-effective treatment and shorter recovery times compared to hospitals. Moreover, growing advancements in implantable device technologies are driving their adoption in outpatient settings. In addition, healthcare cost containment initiatives in several countries further drive demand for this segment.
North America forensic genomics market dominated the global market in 2024. This is due to the strong government investment in forensic technologies to support criminal investigations and enhance national security. Increasing funding from agencies such as the FBI and the Department of Justice accelerated the adoption of advanced DNA analysis tools in the region. Moreover, the presence of established forensic laboratories and technology providers supports large-scale deployment of genomics-based solutions. In addition, the U.S. government’s initiatives to modernize forensic infrastructure and expand national DNA databases created favorable conditions for market growth.
The U.S. Forensic Genomics Market Insight
The U.S. held a dominating market share in the North America forensic genomics landscape in 2024, driven by the rising government funding to strengthen forensic laboratories and law enforcement capabilities. The FBI’s Combined DNA Index System (CODIS) expansion significantly boosted the use of advanced DNA analysis technologies in criminal investigations. Moreover, growing demand for rapid DNA testing to support timely case resolutions is accelerating adoption across local police departments. In addition, strong collaborations between forensic research institutes and biotechnology companies are driving innovation. As an example, in February 2024, Bode Technology launched a complete in-house forensic genetic genealogy service that includes DNA sequencing, analysis, and support. Using the advanced AVITI sequencer, the service delivers high-quality results to help solve complex and challenging DNA cases.
Europe Forensic Genomics Market
The forensic genomics landscape in Europe is projected to hold a substantial share in 2034. This is owing to the rising regulatory support and coordinated cross-border collaboration on forensic data sharing. The European Network of Forensic Science Institutes (ENFSI) played a central role in harmonizing DNA profiling methods across EU nations to strengthen criminal investigation frameworks. Moreover, growing investments in digitized crime databases and advancements in DNA sequencing technologies are increasing efficiency in forensic laboratories. In addition, rising incidences of organized crime and terrorism across European nations are further fueling the demand for advanced forensic genomics solutions.
Asia Pacific Forensic Genomics Market
The market in Asia Pacific is projected to grow at the fastest CAGR during the forecast period. This growth is expanding driven by rapid government investment in modernizing forensic infrastructure to address increasing crime rates. In the countries such as China, India, and Japan are actively expanding forensic laboratories and deploying next-generation sequencing for faster case resolutions. Moreover, rapid urbanization and increasing population density created higher crime-related challenges that require advanced DNA profiling solutions. According to UNICEF, nearly 55% of Asia’s population is expected to live in urban areas by 2030 due to the rapid growth of cities in the region. In addition, growing collaborations between academic institutes, law enforcement, and government agencies in the region are accelerating the adoption of forensic genomics.
China Forensic Genomics Market Overview
The market in China is expanding due to the large-scale government investment in forensic science modernization. The Ministry of Public Security expanded national DNA databases, driving strong demand for advanced sequencing and analysis tools. Moreover, rising crime rates in urban regions increasing reliance on genomics-based identification for faster case resolutions. In addition, local technology firms are collaborating with research institutes to develop cost-effective forensic solutions tailored for high-volume applications, strengthening China’s role as a key growth driver in the Asia Pacific forensic genomics market.
The forensic genomics market is moderately competitive, with leading players focusing on advanced sequencing platforms, consumables, and analytical software to improve accuracy and reduce turnaround time in forensic testing. Companies are expanding their portfolios with integrated NGS systems, PCR solutions, and bioinformatics tools to support criminal investigation and human identification. Moreover, collaborations between forensic laboratories, law enforcement agencies, and technology providers are enabling innovation and driving the adoption of region-specific solutions, strengthening long-term competitiveness across legal, security, and research sectors worldwide.
Major companies operating in the forensic genomics industry include Illumina, Inc., Thermo Fisher Scientific, Qiagen N.V., Agilent Technologies, Inc., Bio-Rad Laboratories, Promega Corporation, Hamilton Company, LGC Limited, Bode Technology Group Inc, Eurofins Scientific, NicheVision Forensics, LLC, MGI Tech Co., Ltd., and InnoGenomics Technologies.
By Product Outlook (Revenue, USD Million, 2020–2034)
By Method Outlook (Revenue, USD Million, 2020–2034)
By Application Outlook (Revenue, USD Million, 2020–2034)
By End User Outlook (Revenue, USD Million, 2020–2034)
By Regional Outlook (Revenue, USD Million, 2020–2034)
Report Attributes |
Details |
Market Size in 2024 |
USD 470.27 Million |
Market Size in 2025 |
USD 538.27 Million |
Revenue Forecast by 2034 |
USD 1,829.15 Million |
CAGR |
14.6% from 2025 to 2034 |
Base Year |
2024 |
Historical Data |
2020–2023 |
Forecast Period |
2025–2034 |
Quantitative Units |
Revenue in USD Million and CAGR from 2025 to 2034 |
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Industry Trends |
Segments Covered |
|
Regional Scope |
|
Competitive Landscape |
|
Report Techniqueat |
|
Customization |
Report customization as per your requirements with respect to countries, regions, and segmentation. |
The global market size was valued at USD 470.27 million in 2024 and is projected to grow to USD 1,829.15 million by 2034.
The global market is projected to register a CAGR of 14.6% during the forecast period.
North America dominated the forensic genomics market in 2024, driven by early adoption of DNA sequencing, forensic databases and rising criminal casework.
A few of the key players in the market are Illumina, Inc., Thermo Fisher Scientific, Qiagen N.V., Agilent Technologies, Inc., Bio-Rad Laboratories, Promega Corporation, Hamilton Company, LGC Limited, Bode Technology Group Inc, Eurofins Scientific, NicheVision Forensics, LLC, MGI Tech Co., Ltd., and InnoGenomics Technologies.
The instruments segment dominated the market in 2024, driven by adoption of sequencing systems, PCR platforms and electrophoresis tools.
The PCR segment is projected to grow at the fastest CAGR, due to its ability to rapidly amplify small DNA samples at lower cost.